BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 28938748)

  • 21. Timing of fertility preservation procedures in a cohort of female patients with cancer.
    Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?
    Benvenuti C; Laot L; Grinda T; Lambertini M; Pistilli B; Grynberg M
    ESMO Open; 2024 Feb; 9(2):102228. PubMed ID: 38232611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility preservation in the male pediatric population: factors influencing the decision of parents and children.
    Wyns C; Collienne C; Shenfield F; Robert A; Laurent P; Roegiers L; Brichard B
    Hum Reprod; 2015 Sep; 30(9):2022-30. PubMed ID: 26141713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
    Kim J; Turan V; Oktay K
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience of young women diagnosed with breast cancer who undergo fertility preservation consultation.
    Hill KA; Nadler T; Mandel R; Burlein-Hall S; Librach C; Glass K; Warner E
    Clin Breast Cancer; 2012 Apr; 12(2):127-32. PubMed ID: 22444719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciding about fertility preservation after specialist counselling.
    Bastings L; Baysal Ö; Beerendonk CC; IntHout J; Traas MA; Verhaak CM; Braat DD; Nelen WL
    Hum Reprod; 2014 Aug; 29(8):1721-9. PubMed ID: 24916435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis.
    Silva C; Caramelo O; Almeida-Santos T; Ribeiro Rama AC
    Hum Reprod; 2016 Dec; 31(12):2737-2749. PubMed ID: 27664208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
    Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
    J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
    Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
    J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of early referral to fertility preservation in young women with breast cancer.
    Lee S; Ozkavukcu S; Heytens E; Moy F; Oktay K
    J Clin Oncol; 2010 Nov; 28(31):4683-6. PubMed ID: 20876425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assisted reproductive technology use and outcomes among women with a history of cancer.
    Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
    Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model.
    Kawahara T; Okamoto N; Takae S; Kashiwagi M; Nakajima M; Uekawa A; Ito J; Kashiwazaki N; Sugishita Y; Suzuki N
    Hum Reprod; 2018 Feb; 33(2):303-310. PubMed ID: 29300901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time from referral to ovarian tissue cryopreservation in a cohort of Danish women.
    Kristensen SG; Pors SE; Poulsen LC; Andersen ST; Wakimoto Y; Yding Andersen C
    Acta Obstet Gynecol Scand; 2019 May; 98(5):616-624. PubMed ID: 30758835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
    Moravek MB; Confino R; Lawson AK; Smith KN; Kazer RR; Klock SC; Gradishar WJ; Jeruss JS; Pavone ME
    Breast Cancer Res Treat; 2021 Apr; 186(2):429-437. PubMed ID: 33392838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
    Courbiere B; Decanter C; Bringer-Deutsch S; Rives N; Mirallié S; Pech JC; De Ziegler D; Carré-Pigeon F; May-Panloup P; Sifer C; Amice V; Schweitzer T; Porcu-Buisson G; Poirot C;
    Hum Reprod; 2013 Sep; 28(9):2381-8. PubMed ID: 23832792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
    Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
    Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
    Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
    Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
    İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
    Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.